Log In
Print this Print this

ALKS 8700

  Manage Alerts
Collapse Summary General Information
Company Alkermes plc
DescriptionSmall molecule prodrug of monomethyl fumarate (MMF)
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat multiple sclerosis (MS)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today